Intellia Therapeutics, Inc.
Assets & Liabilities
| Fiscal Year | Total Liabilities | Total Assets | Cash on Hand |
|---|---|---|---|
| FY2016 | $89.1M | $299.0M | $273.1M |
| FY2017 | $75.6M | $376.2M | $340.7M |
| FY2018 | $69.4M | $347.3M | $58.9M |
| FY2019 | $64.4M | $334.3M | $57.2M |
| FY2020 | $149.3M | $676.3M | $160.0M |
| FY2021 | $254.2M | $1.29B | $123.4M |
| FY2022 | $284.5M | $1.52B | $523.5M |
| FY2023 | $250.8M | $1.30B | $226.7M |
| FY2024 | $319.1M | $1.19B | $189.2M |
| FY2025 | $170.7M | $842.1M | $155.5M |